Palisade Bio (PALI)
(Delayed Data from NSDQ)
$0.88 USD
-0.12 (-12.16%)
Updated Aug 7, 2025 04:00 PM ET
After-Market: $0.79 -0.09 (-10.06%) 5:52 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Palisade Bio, Inc. has a market cap of $4.80M, which represents its share price of $1.00 multiplied by its outstanding shares number of 4.80M. As a small-cap company, PALI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PALI 0.88 -0.12(-12.16%)
Will PALI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PALI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PALI
Palisade Bio (PALI) Upgraded to Buy: What Does It Mean for the Stock?
PALI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PALI
Palisade Bio Reports 100% Clinical Response in Phase 1b Ulcerative Colitis Cohort with Novel ...
Palisade Bio announces new data from ongoing program evaluating PALI-2108
Palisade Bio (PALI) Secures Key Patent Approval in China
Palisade Bio Receives Notice of Allowance for Composition of Matter Patent Covering Lead ...
Palisade Bio receives notice of allowance for patent of PALI-2108 in China